The payer received the notice after its average stock price failed to meet the threshold for the 30-day trading period that ended Dec. 2, according to the report. It has six months to regain compliance from the receipt of the Dec. 6 notice.
The company went public in June 2021 at $18 per share, according to the report. The stock has since lost 95 percent of its value. On Dec. 12, the stock closed at 87 cents a share.
Bright Health said in a statement that it “intends to consider available alternatives, including, but not limited to, a reverse stock split, subject to stockholder approval no later than at the company’s next annual meeting of stockholders, if necessary, to regain compliance,” according to the report.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
